Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms. In January 2015, Flex Pharma went public (NASDAQ: FLKS).
Location: United States, Massachusetts, Boston
Total raised: $40M
Investors 3
Date | Name | Website |
- | Bessemer V... | bvp.com |
- | EcoR1 Capi... | ecor1cap.c... |
- | Lightstone... | lightstone... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
09.09.2014 | - | $40M | - | finsmes.co... |
Mentions in press and media 6
Date | Title | Description | Source |
04.08.2017 | Big Pharma veterans at Pfizer, AstraZeneca join the gre... | → Biogen has recruited Anabella Villalobos as its new SVP of biotherapeutic & medic... | endpts.com... |
31.07.2017 | AstraZeneca bags a ‘breakthrough’ for bruised checkpoint ... | → Just days after a damaging failure for duvalumab (Imfinzi) in a combination approach to... | endpts.com... |
06.06.2017 | Tiny Flex Pharma’s CEO Westphal steps down | Flex Pharma is on the lookout for a new chief after co-founder Christoph Westphal, M.D., Ph.D., is s... | fiercebiot... |
06.06.2017 | Tiny Flex Pharma’s CEO Westphal steps down | Flex Pharma is on the lookout for a new chief after co-founder Christoph Westphal, M.D., Ph.D., is s... | fiercebiot... |
09.09.2014 | Flex Pharma Raises $40M in Funding | Flex Pharma, Inc., a Boston MA-based biopharmaceutical company that develops treatments for neuromus... | finsmes.co... |
09.09.2014 | Flex Pharma Raises $40M | BOSTON, MA, Biopharmaceutical company dedicated to creating innovative, novel treatments for neuro... | vcnewsdail... |